Literature DB >> 28506693

Survival prediction of non-small cell lung cancer patients using radiomics analyses of cone-beam CT images.

Janna E van Timmeren1, Ralph T H Leijenaar2, Wouter van Elmpt2, Bart Reymen2, Cary Oberije2, René Monshouwer3, Johan Bussink3, Carsten Brink4, Olfred Hansen5, Philippe Lambin2.   

Abstract

BACKGROUND AND
PURPOSE: In this study we investigated the interchangeability of planning CT and cone-beam CT (CBCT) extracted radiomic features. Furthermore, a previously described CT based prognostic radiomic signature for non-small cell lung cancer (NSCLC) patients using CBCT based features was validated.
MATERIAL AND METHODS: One training dataset of 132 and two validation datasets of 62 and 94stage I-IV NSCLC patients were included. Interchangeability was assessed by performing a linear regression on CT and CBCT extracted features. A two-step correction was applied prior to model validation of a previously published radiomic signature. Results 13.3% (149 out of 1119) of the radiomic features, including all features of the previously published radiomic signature, showed an R2 above 0.85 between intermodal imaging techniques. For the radiomic signature, Kaplan-Meier curves were significantly different between groups with high and low prognostic value for both modalities. Harrell's concordance index was 0.69 for CT and 0.66 for CBCT models for dataset 1. Conclusions The results show that a subset of radiomic features extracted from CT and CBCT images are interchangeable using simple linear regression. Moreover, a previously developed radiomics signature has prognostic value for overall survival in three CBCT cohorts, showing the potential of CBCT radiomics to be used as prognostic imaging biomarker.
Copyright © 2017 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Computed tomography; Cone-beam CT; Non-small cell lung cancer; Radiomics; Survival prediction

Mesh:

Year:  2017        PMID: 28506693     DOI: 10.1016/j.radonc.2017.04.016

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  41 in total

1.  Prediction of disease-free survival by the PET/CT radiomic signature in non-small cell lung cancer patients undergoing surgery.

Authors:  Margarita Kirienko; Luca Cozzi; Lidija Antunovic; Lisa Lozza; Antonella Fogliata; Emanuele Voulaz; Alexia Rossi; Arturo Chiti; Martina Sollini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-09-24       Impact factor: 9.236

Review 2.  The role of radiomics in prostate cancer radiotherapy.

Authors:  Rodrigo Delgadillo; John C Ford; Matthew C Abramowitz; Alan Dal Pra; Alan Pollack; Radka Stoyanova
Journal:  Strahlenther Onkol       Date:  2020-08-21       Impact factor: 3.621

3.  Machine Learning Methods for Optimal Radiomics-Based Differentiation Between Recurrence and Inflammation: Application to Nasopharyngeal Carcinoma Post-therapy PET/CT Images.

Authors:  Dongyang Du; Hui Feng; Wenbing Lv; Saeed Ashrafinia; Qingyu Yuan; Quanshi Wang; Wei Yang; Qianjin Feng; Wufan Chen; Arman Rahmim; Lijun Lu
Journal:  Mol Imaging Biol       Date:  2020-06       Impact factor: 3.488

4.  Exploratory ensemble interpretable model for predicting local failure in head and neck cancer: the additive benefit of CT and intra-treatment cone-beam computed tomography features.

Authors:  Howard E Morgan; Kai Wang; Michael Dohopolski; Xiao Liang; Michael R Folkert; David J Sher; Jing Wang
Journal:  Quant Imaging Med Surg       Date:  2021-12

Review 5.  Anatomic, functional and molecular imaging in lung cancer precision radiation therapy: treatment response assessment and radiation therapy personalization.

Authors:  Michael MacManus; Sarah Everitt; Tanja Schimek-Jasch; X Allen Li; Ursula Nestle; Feng-Ming Spring Kong
Journal:  Transl Lung Cancer Res       Date:  2017-12

6.  Analysis of primary tumor metabolic volume during chemoradiotherapy in locally advanced non-small cell lung cancer.

Authors:  Olarn Roengvoraphoj; Cherylina Wijaya; Chukwuka Eze; Minglun Li; Maurice Dantes; Julian Taugner; Amanda Tufman; Rudolf Maria Huber; Claus Belka; Farkhad Manapov
Journal:  Strahlenther Onkol       Date:  2017-11-07       Impact factor: 3.621

7.  Radiomics-based predictive risk score: A scoring system for preoperatively predicting risk of lymph node metastasis in patients with resectable non-small cell lung cancer.

Authors:  Lan He; Yanqi Huang; Lixu Yan; Junhui Zheng; Changhong Liang; Zaiyi Liu
Journal:  Chin J Cancer Res       Date:  2019-08       Impact factor: 5.087

8.  Radiomics of 18F Fluorodeoxyglucose PET/CT Images Predicts Severe Immune-related Adverse Events in Patients with NSCLC.

Authors:  Wei Mu; Ilke Tunali; Jin Qi; Matthew B Schabath; Robert James Gillies
Journal:  Radiol Artif Intell       Date:  2020-01-29

9.  Prognostic Value of Pre-Treatment CT Radiomics and Clinical Factors for the Overall Survival of Advanced (IIIB-IV) Lung Adenocarcinoma Patients.

Authors:  Duo Hong; Lina Zhang; Ke Xu; Xiaoting Wan; Yan Guo
Journal:  Front Oncol       Date:  2021-05-28       Impact factor: 6.244

Review 10.  Artificial Intelligence Applications to Improve the Treatment of Locally Advanced Non-Small Cell Lung Cancers.

Authors:  Andrew Hope; Maikel Verduin; Thomas J Dilling; Ananya Choudhury; Rianne Fijten; Leonard Wee; Hugo Jwl Aerts; Issam El Naqa; Ross Mitchell; Marc Vooijs; Andre Dekker; Dirk de Ruysscher; Alberto Traverso
Journal:  Cancers (Basel)       Date:  2021-05-14       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.